Broad spectrum vaccine against gonorrhea
US4622223A · kind A · utility
3Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 25, 1985 |
| Grant date | Nov 11, 1986 |
| Priority date | — |
| Expiry date | Jul 25, 2005 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Vaccines comprising peptide sequences corresponding to immunorecessive determinants in gonorrhea pilus protein are disclosed. The vaccines are effective in protecting human subjects against infection by a wide range of gonorrhea strains by raising antibodies which interfere with the colonization of the epithelium by the infecting bacteria or which enhance phagocytosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.